In-house program
Eli Lilly · LY4052031 Eli Lilly · LY4101174 Eli Lilly · Sofetabart mipitecan AbbVie · ABBV-368 AbbVie · ABBV-927 AbbVie · Budigalimab AbbVie · Navitoclax AbbVie · Telisotuzumab adizutecan Novartis · DFC413 Novartis · NNS309 Amgen · AMG 650 Gilead Sciences · GS-0201 Bayer · BAY 3375968 Vertex Pharmaceuticals · Berzosertib Otsuka Holdings · Tolinapant Incyte · INCB123667 Pfizer · Gedatolisib Pfizer · Ivuxolimab Pfizer · Utomilumab AstraZeneca · Cediranib AstraZeneca · Ceralasertib AstraZeneca · Oleclumab AstraZeneca · Tremelimumab AstraZeneca · Vistusertib Roche · Tiragolumab Novartis · Buparlisib Novartis · Spartalizumab Bristol Myers Squibb · AL101 Bristol Myers Squibb · BMS-986449 Bristol Myers Squibb · Ipilimumab Bristol Myers Squibb · Nivolumab GSK · Trametinib Takeda · Alisertib Regeneron Pharmaceuticals · Cemiplimab Regeneron Pharmaceuticals · Fianlimab Astellas Pharma · Enfortumab vedotin Daiichi Sankyo · Patritumab deruxtecan Menarini · MEN1611 Eisai · Farletuzumab ecteribulin Eisai · Lenvatinib Incyte · Retifanlimab Sino Biopharmaceutical · TQB2102 Sino Biopharmaceutical · TQB2868 Jiangsu Hengrui Pharmaceuticals · Retlirafusp alfa Jiangsu Hengrui Pharmaceuticals · SHR-A1921 Jiangsu Hengrui Pharmaceuticals · SHR-A2009 Jiangsu Hengrui Pharmaceuticals · SHR-A2102 AbbVie · Veliparib AstraZeneca · Capivasertib AstraZeneca · Durvalumab Roche · Bevacizumab Roche · Ipatasertib Novartis · Everolimus Merck KGaA · Avelumab Sino Biopharmaceutical · Anlotinib Sino Biopharmaceutical · Benmelstobart Jiangsu Hengrui Pharmaceuticals · Adebrelimab Jiangsu Hengrui Pharmaceuticals · Apatinib Jiangsu Hengrui Pharmaceuticals · Camrelizumab Jiangsu Hengrui Pharmaceuticals · Famitinib Jiangsu Hengrui Pharmaceuticals · Fuzuloparib Jiangsu Hengrui Pharmaceuticals · Trastuzumab rezetecan Roche · Atezolizumab Daiichi Sankyo · Datopotamab deruxtecan Daiichi Sankyo · Trastuzumab deruxtecan Acquired program
Pfizer · Binimetinib Bristol Myers Squibb · Sitravatinib Regeneron Pharmaceuticals · Vidutolimod Sino Biopharmaceutical · LM-108 Pfizer · Enzalutamide GSK · Niraparib Gilead Sciences · Sacituzumab govitecan Partnership
AbbVie · ABBV-461 / CLBR001 Roche · Autogene cevumeran GSK · HS-20093 Takeda · IBI363 Merck & Co. · Ladiratuzumab vedotin Merck & Co. · Patritumab deruxtecan Pfizer · Disitamab vedotin Pfizer · Enfortumab vedotin AbbVie · RC148 GSK · Mo-Rez Pfizer · Avelumab Bristol Myers Squibb · Izalontamab brengitecan Bristol Myers Squibb · Pumitamig Merck & Co. · Sacituzumab tirumotecan AstraZeneca · Datopotamab deruxtecan AstraZeneca · Trastuzumab deruxtecan Chugai Pharmaceutical · Atezolizumab Discontinued program Sun Pharmaceutical Industries · sunpharma-vcr-pld
Eli Lilly · Crenigacestat Eli Lilly · Galunisertib Eli Lilly · LY3143921 Eli Lilly · LY3300054 Eli Lilly · LY3381916 Merck & Co. · Birabresib Merck & Co. · Dalotuzumab Merck & Co. · Dinaciclib Merck & Co. · Gebasaxturev Merck & Co. · MK-0482 Merck & Co. · MK-4830 Merck & Co. · Ulevostinag Pfizer · Cofetuzumab pelidotin Pfizer · Dacomitinib Pfizer · Felmetatug vedotin Pfizer · PF-06647263 Pfizer · PF-06936308 Pfizer · PF-07224826 AbbVie · Losatuxizumab vedotin AbbVie · SC-005 AstraZeneca · AZD8186 AstraZeneca · AZD8701 AstraZeneca · FPI-1434 / FPI-1175 Roche · Navoximod Roche · RO6870810 Roche · RO7296682 Novartis · Canakinumab Novartis · Capmatinib Novartis · CJM112 Novartis · FAZ053 Novartis · KFA115 Novartis · LGK974 Novartis · Nazartinib Novartis · PCA062 Novartis · QBM076 Novartis · Siremadlin Novartis · Sonidegib Sanofi · SAR428926 GSK · GSK3145095 GSK · Pemrametostat Amgen · Cabiralizumab Boehringer Ingelheim · Ezabenlimab Takeda · Dazostinag Takeda · Mivavotinib Gilead Sciences · CART-TnMUC1 Bayer · BAY 1187982 Otsuka Holdings · Onalespib Merck KGaA · Tuvusertib Ipsen · Irinotecan liposome Eli Lilly · LY3295668 Eli Lilly · Prexasertib Eli Lilly · Samotolisib Merck & Co. · Boserolimab Merck & Co. · MK-2206 Merck & Co. · Zilovertamab vedotin Pfizer · Ebvaciclib Pfizer · Ladiratuzumab vedotin Pfizer · Nirogacestat Pfizer · PD-0360324 Pfizer · Sunitinib AbbVie · Ibrutinib AbbVie · IMGC936 AstraZeneca · Adavosertib AstraZeneca · Saracatinib Roche · Cobimetinib Roche · Onartuzumab Roche · Pictilisib Roche · RO4929097 Roche · Taselisib Roche · Tobemstomig Novartis · Ieramilimab Novartis · Lacnotuzumab Novartis · LCL161 Novartis · Taminadenant Novartis · Trametinib Sanofi · Alomfilimab Sanofi · SAR566658 Bristol Myers Squibb · BMS-986178 Bristol Myers Squibb · BMS-986249 Bristol Myers Squibb · Dasatinib GSK · Uprosertib Amgen · Bemarituzumab Amgen · Ganitumab Amgen · Talimogene laherparepvec Amgen · Trebananib Boehringer Ingelheim · Brigimadlin Takeda · Orteronel Takeda · Sapanisertib Takeda · Serabelisib Gilead Sciences · Magrolimab Daiichi Sankyo · Pexidartinib Daiichi Sankyo · Tigatuzumab Otsuka Holdings · Futibatinib Merck KGaA · Bintrafusp alfa Merck KGaA · Cetuximab Servier · S81694 Eisai · E7449 Incyte · Epacadostat Jazz Pharmaceuticals · Dordaviprone Kyowa Kirin · UCN-01 Novartis · Alpelisib Sanofi · Iniparib Shanghai Pharmaceuticals Holding · B013
Academic trial support
Merck & Co. · ASTX660; Pembrolizumab Merck & Co. · Azenosertib; Carboplatin; Pembrolizumab Merck & Co. · Dinaciclib; Pembrolizumab Merck & Co. · Pembrolizumab; PVX-410 Pfizer · Palbociclib; Avelumab Pfizer · Talazoparib; ASTX727 Pfizer · Temsirolimus; Cisplatin; Erlotinib AbbVie · Combination of Veliparib + Lapatinib AstraZeneca · BKM120 and Olaparib; BYL719 and Olaparib AstraZeneca · Docetaxel; PI3Kbeta Inhibitor AZD8186 AstraZeneca · Durvalumab; Neoantigen DNA vaccine AstraZeneca · Durvalumab; Tremelimumab AstraZeneca · Olaparib; Onalespib AstraZeneca · PVX-410; Durvalumab; Hiltonol Roche · Temsirolimus; Cisplatin; Erlotinib Novartis · BKM120 and Olaparib; BYL719 and Olaparib Novartis · everolimus; eribulin mesylate Novartis · LDE225; Docetaxel Novartis · Ribociclib; Belinostat Bristol Myers Squibb · Cabozantinib S-malate; Nivolumab GSK · Combination of Veliparib + Lapatinib GSK · GSK1120212 GSK · Niraparib GSK · Niraparib; Doxorubicin; Cyclophosphamide; Paclitaxel; Pegfilgrastim; Carboplatin Astellas Pharma · Metformin; Erlotinib Otsuka Holdings · ASTX660; Pembrolizumab Otsuka Holdings · Olaparib; Onalespib Otsuka Holdings · Talazoparib; ASTX727 Merck KGaA · Brachyury-TRICOM; Entinostat; M7824; Ado-trastuzumab emtansine Eisai · everolimus; eribulin mesylate Incyte · Parsaclisib Eli Lilly · Abemaciclib Eli Lilly · Abemaciclib Eli Lilly · Abemaciclib; Bicalutamide Eli Lilly · Drug 1: LY3023414; Drug 2: Prexasertib Eli Lilly · Experimental Arm A: Pemetrexed; Experimental Arm A: Sorafenib; Experimental Arm B: Pemetrexed; Experimental Arm B: Sorafenib Eli Lilly · LY2606368 Eli Lilly · Panitumumab; Carboplatin; Gemcitabine Eli Lilly · Tamoxifen; Anastrozole; Degarelix; Abemaciclib Merck & Co. · ADV/HSV-tk; Valacyclovir; Pembrolizumab Merck & Co. · Docetaxel; Pembrolizumab; IL-12 gene therapy Merck & Co. · Doxorubicin; Cyclophosphamide; Paclitaxel; Carboplatin; Decitabine; Pembrolizumab Merck & Co. · Pembrolizumab & ADG106 (Phase Ib); Pembrolizumab & ADG106 (Phase II) Merck & Co. · Pembrolizumab; Axatilimab Merck & Co. · Pembrolizumab; Axatilimab Merck & Co. · Pembrolizumab; IRX 2 Merck & Co. · Pembrolizumab; Liposomal Irinotecan Merck & Co. · Pembrolizumab; Paclitaxel; Bevacizumab Merck & Co. · Sacituzumab Govitecan; Pembrolizumab Merck & Co. · Sacituzumab tirumotecan Merck & Co. · Trilaciclib; Pembrolizumab; Gemcitabine; Carboplatin Pfizer · ALX148; Fam-Trastuzumab Deruxtecan-Nxki; Zanidatamab; Tucatinib; TTX-MC138 Pfizer · Anti-OX40 Antibody PF-04518600; Avelumab; Binimetinib; Utomilumab; Liposomal Doxorubicin; Sacituzumab Govitecan Pfizer · Binimetinib; Pembrolizumab Pfizer · Capecitabine; Talazoparib; Pembrolizumab; Inavolisib Pfizer · Combination, Palbociclib + Binimetinib Pfizer · Crizotinib Oral Capsule [Xalkori]; Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic] Pfizer · Gedatolisib; Talazoparib Pfizer · Neoadjuvant tamoxifen + goserelin (premenopausal women); Neoadjuvant letrozole (postmenopausal women); Neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone); Neoadjuvant docetaxel + cyclophosphamide; Neoadjuvant docetaxel; Neoadjuvant docetaxel + trastuzumab + pertuzumab; Neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab; Neoadjuvant olaparib; Neoadjuvant cyclophosphamide (after 10 weeks of olaparib alone); Adjuvant trastuzumab; Adjuvant letrozole (postmenopausal women); Adjuvant tamoxifen + goserelin (premenopausal women); Adjuvant palbociclib (if palbociclib given neoadjuvant); Adjuvant Epirubicin+ Cyclophosphamide Pfizer · Paclitaxel; Carboplatin; Sunitinib Pfizer · Talazoparib; Atezolizumab AbbVie · Cisplatin; Veliparib AbbVie · Veliparib AstraZeneca · AZD2014; AZD6244 AstraZeneca · AZD6738; Olaparib; Durvalumab AstraZeneca · Capivasertib; Ceralasertib; Durvalumab; Olaparib; Selumetinib AstraZeneca · Cediranib Maleate; Olaparib AstraZeneca · Ceralasertib; Durvalumab; Nab-paclitaxel AstraZeneca · CFI-400945; Durvalumab AstraZeneca · Cisplatin; AZD1775 AstraZeneca · Dato-DXd; Durvalumab AstraZeneca · Datopotamab deruxtecan AstraZeneca · Datopotamab Deruxtecan (Dato-DXd); Durvalumab AstraZeneca · Durvalumab AstraZeneca · Durvalumab; Carboplatin; Paclitaxel AstraZeneca · entinostat; anastrozole AstraZeneca · MEDI4736 AstraZeneca · MEDI4736 (Anti PD-L1); Placebo; nab-Paclitaxel; Epirubicin; Cyclophosphamide AstraZeneca · Neoadjuvant tamoxifen + goserelin (premenopausal women); Neoadjuvant letrozole (postmenopausal women); Neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone); Neoadjuvant docetaxel + cyclophosphamide; Neoadjuvant docetaxel; Neoadjuvant docetaxel + trastuzumab + pertuzumab; Neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab; Neoadjuvant olaparib; Neoadjuvant cyclophosphamide (after 10 weeks of olaparib alone); Adjuvant trastuzumab; Adjuvant letrozole (postmenopausal women); Adjuvant tamoxifen + goserelin (premenopausal women); Adjuvant palbociclib (if palbociclib given neoadjuvant); Adjuvant Epirubicin+ Cyclophosphamide AstraZeneca · Olaparib Oral Product; Olaparib Oral Product in combination with Durvalumab AstraZeneca · Olaparib; Durvalumab AstraZeneca · olaparib; Durvalumab AstraZeneca · Paclitaxel; AZD5363; Placebo AstraZeneca · Paclitaxel; Carboplatin; MEDI4736; MEDI9447 AstraZeneca · Paclitaxel; Durvalumab Roche · Abraxane; Bevacizumab; Carboplatin Roche · Association atezolizumab + BDB001 + RT; Association atezolizumab + BDB001+ RT; Association atezolizumab + BDB001+ RT; Association atezolizumab + BDB001 + RT; Association atezolizumab + BDB001 + RT; Association atezolizumab + BDB001 + RT Roche · Atezolizumab Roche · Atezolizumab + RP1 Roche · Atezolizumab Injection; Bevacizumab; Pertuzumab; Trastuzumab Roche · Atezolizumab; Capecitabine; Carboplatin; Ipatasertib; Paclitaxel Roche · Atezolizumab; Carboplatin Roche · Atezolizumab; Carboplatin; Paclitaxel Roche · Atezolizumab; Ipatasertib; Paclitaxel; Doxorubicin; Cyclophosphamide Roche · Atezolizumab; Nab-paclitaxel Roche · Atezolizumab; Paclitaxel; Bevacizumab Roche · Atezolizumab; Pegylated liposomal doxorubicin; Cyclophosphamide Roche · Atezolizumab; Sacituzumab govitecan Roche · bendamustine; erlotinib; Maintenance erlotinib Roche · Bevacizumab, Abraxane Roche · Bevacizumab, nab-paclitaxel, carboplatin, doxorubicin hydrochloride, cyclophosphamide, PEG-Filgrastim Roche · Cabozantinib; Trastuzumab Roche · Capecitabine and Bevacizumab Roche · Capecitabine; Talazoparib; Pembrolizumab; Inavolisib Roche · Carbo/cyclo; Carbo/cyclo + atezolizumab; Paclitaxel; Paclitaxel + Atezolizumab Roche · cisplatin; bevacizumab; doxorubicin; cyclophosphamide; paclitaxel Roche · cisplatin; GDC -0941 Roche · Doxorubicin; Cyclophosphamide; Paclitaxel; Bevacizumab Roche · Enzalutamide; Taselisib Roche · Erlotinib with neoadjuvant chemotherapy Roche · Ipatasertib; Capecitabine; Eribulin; Carboplatin; Gemcitabine Roche · SOC Chemotherapy; Tocilizumab/Tocilizumab Biosimilar Roche · Talazoparib; Atezolizumab Roche · Tiragolumab; Atezolizumab; Ipilimumab Novartis · Akt Inhibitor GSK2141795; Trametinib Novartis · BKM120 Novartis · Carboplatin; Everolimus Novartis · Decitabine, LBH589, Tamoxifen Novartis · Everolimus Novartis · L-NMMA Novartis · Paclitaxel; 5-Fluorouracil; Epirubicin; Cyclophosphamide; RAD001 Novartis · RAD 001 Novartis · RAD001; Carboplatin Novartis · ribociclib; ribociclib; Bicalutamide Novartis · Spartalizumab; Tislelizumab Sanofi · Cetuximab; Docetaxel Sanofi · Gemcitabine; Oxaliplatin Bristol Myers Squibb · Carboplatin; Nivolumab Bristol Myers Squibb · Cetuximab; Ixabepilone Bristol Myers Squibb · Dasatinib Bristol Myers Squibb · Nivolumab 360mg; Paclitaxel 80mg/m^2; Doxorubicin 60mg/m^2; Cyclophosphamide 600mg/m^2; Paclitaxel 80mg/m^2 or Docetaxel 75mg/m^2; Trastuzumab 8mg/kg and 6 mg/kg; Pertuzumab 840mg and 420mg Bristol Myers Squibb · Nivolumab; Cabozantinib Bristol Myers Squibb · Nivolumab; Capecitabine Bristol Myers Squibb · Nivolumab; Cisplatin; Low dose doxorubicin Bristol Myers Squibb · Nivolumab; Ipilimumab Bristol Myers Squibb · Nivolumab; Ipilimumab; Ipilimumab Bristol Myers Squibb · Nivolumab; Low dose doxorubicin; Cyclophosphamide; Cisplatin Bristol Myers Squibb · Paclitaxel; Carboplatin; Nivolumab; Cabiralizumab Bristol Myers Squibb · Pembrolizumab; Ipilimumab; Nivolumab Bristol Myers Squibb · Relatlimab FDC + Nivolumab; Sacituzumab Govitecan (SG); Nivolumab Bristol Myers Squibb · Romidepsin; Cisplatin; Nivolumab GSK · Akt Inhibitor GSK2141795; Trametinib GSK · Niraparib; Dostarlimab Amgen · Carboplatin; Paclitaxel; Panitumumab Amgen · Denosumab; nab-Paclitaxel; Epirubicin; Cyclophosphamide; Carboplatin; Trastuzumab; Pertuzumab Amgen · Panitumumab; Carboplatin; Gemcitabine Amgen · Sorafenib; Cisplatin; Paclitaxel Amgen · Talimogene laherparepvec; Paclitaxel Boehringer Ingelheim · Ezabenlimab + BI907828 Takeda · Ixazomib; Carboplatin Takeda · Orteronel Takeda · Tak-228 & Tak-117; Cisplatin & Nab Paclitaxel Gilead Sciences · Anti-OX40 Antibody PF-04518600; Avelumab; Binimetinib; Utomilumab; Liposomal Doxorubicin; Sacituzumab Govitecan Gilead Sciences · Debio 0123 and Sacituzumab govitecan Gilead Sciences · Sacituzumab govitecan; Loperamide; Granulocyte Colony-Stimulating Factor Gilead Sciences · Sacituzumab Govitecan; Pembrolizumab Gilead Sciences · Sacituzumab Govitecan; Pembrolizumab Gilead Sciences · Sacituzumab Govitecan; Pembrolizumab Gilead Sciences · Zimberelimab; Sacituzumab govitecan Bayer · Copanlisib Hydrochloride; Eribulin Mesylate Bayer · Experimental Arm A: Pemetrexed; Experimental Arm A: Sorafenib; Experimental Arm B: Pemetrexed; Experimental Arm B: Sorafenib Bayer · Sorafenib; Cisplatin; Paclitaxel Teva · Abemaciclib; Bicalutamide Regeneron Pharmaceuticals · Cemiplimab; Paclitaxel; Carboplatin (not mandatory); Doxorubicin; Cyclophosphamide Astellas Pharma · Enzalutamide Astellas Pharma · Enzalutamide; Exemestane Astellas Pharma · Enzalutamide; Mifepristone; TPC Daiichi Sankyo · Abraxane alone; Abraxane + Tigatuzumab Daiichi Sankyo · Datopotamab deruxtecan Daiichi Sankyo · Datopotamab Deruxtecan Daiichi Sankyo · U3-1402 Merck KGaA · Bintrafusp Alfa; Pimasertib Merck KGaA · Cetuximab; Docetaxel UCB · UCB4594 Menarini · MEN1611; Eribulin Eisai · Decitabine, LBH589, Tamoxifen Eisai · Pembrolizumab; Lenvatinib Incyte · Pelareorep; Retifanlimab Incyte · Pembrolizumab; Axatilimab Incyte · Pembrolizumab; Axatilimab Incyte · Ruxolitinib; Paclitaxel Incyte · Ruxolitinib; Paclitaxel; Doxorubicin; Cyclophosphamide Jiangsu Hengrui Pharmaceuticals · Apatinib Jiangsu Hengrui Pharmaceuticals · Apatinib Jiangsu Hengrui Pharmaceuticals · Camrelizumab; Apatinib; Nab-paclitaxel; Epirubicin; Cyclophosphamide Jiangsu Hengrui Pharmaceuticals · Camrelizumab; Liposomal Doxorubicin; Losartan Jiangsu Hengrui Pharmaceuticals · Camrelizumab; Nab paclitaxel; Epirubicin; Cyclophosphamide Jiangsu Hengrui Pharmaceuticals · Fluzoparib+Paclitaxel; Epirubicin+Cyclophosphamide Jiangsu Hengrui Pharmaceuticals · Pyrotinib; SHR6390; Letrozole; Capecitabine Jiangsu Hengrui Pharmaceuticals · SHR-1316 at a dose 20mg/kg q3w; SHR6390 at a dose of 150mg orally, daily Ipsen · Pembrolizumab; Liposomal Irinotecan Jazz Pharmaceuticals · ALX148; Fam-Trastuzumab Deruxtecan-Nxki; Zanidatamab; Tucatinib; TTX-MC138 Merck & Co. · Sacituzumab govitecan; Pembrolizumab Roche · Carboplatin; background treatment Roche · non-pegylated liposomal doxorubicin; Carboplatin; Paclitaxel; Epirubicin; Cyclophosphamide; Pertuzumab; Trastuzumab; Ferric carboxymaltose Roche · Placebo; Atezolizumab Novartis · Ribociclib + Letrozole OR Fulvestrant; Palbociclib + Letrozole OR Fulvestrant; Paclitaxel +/- Tislelizumab GSK · Carboplatin; background treatment Amgen · non-pegylated liposomal doxorubicin; Carboplatin; Paclitaxel; Epirubicin; Cyclophosphamide; Pertuzumab; Trastuzumab; Ferric carboxymaltose Gilead Sciences · Capecitabine; Carboplatin; Cisplatin; Sacituzumab govitecan Gilead Sciences · Sacituzumab govitecan Gilead Sciences · Sacituzumab govitecan; Pembrolizumab Gilead Sciences · Sacituzumab govitecan; Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]; SoC Chemotherapy Teva · Carboplatin; background treatment Teva · non-pegylated liposomal doxorubicin; Carboplatin; Paclitaxel; Epirubicin; Cyclophosphamide; Pertuzumab; Trastuzumab; Ferric carboxymaltose Jiangsu Hengrui Pharmaceuticals · Camrelizumab; Nab-Paclitaxel; Carboplatin Jiangsu Hengrui Pharmaceuticals · capecitabine; capecitabine + camrelizumab + apatinib
Generics of the standard-of-care drug
Pfizer · Carboplatin (generic) Pfizer · Doxorubicin (generic) Pfizer · Epirubicin (generic) Pfizer · Paclitaxel (generic) Bristol Myers Squibb · Doxorubicin (generic) Teva · Capecitabine (generic) Teva · Carboplatin (generic) Teva · Cyclophosphamide (generic) Teva · Doxorubicin (generic) Teva · Epirubicin (generic) Teva · Paclitaxel (generic) Viatris · Doxorubicin (generic) Sandoz · Carboplatin (generic) Sandoz · Epirubicin (generic) Sandoz · Paclitaxel (generic) Sun Pharmaceutical Industries · Capecitabine (generic) Sun Pharmaceutical Industries · Carboplatin (generic) Sun Pharmaceutical Industries · Doxorubicin (generic) Jiangsu Hengrui Pharmaceuticals · Cyclophosphamide (generic) Dr. Reddy's Laboratories · Capecitabine (generic)